Johnson & Johnson is dealing with another recall – this time, the recall is due to a typo on 667,000 Sudafed packages.
McNeil Consumer Healthcare recalled the decongestant because the dosing label includes an extra "not" in the instructions. The packages reportedly say "do not not divide, crush, chew, or dissolve the tablet."
The J&J division has faced ongoing manufacturing issues in the last year, most recently announcing the recall of 43 million packages of Tylenol, Benadryl, Sudafed, and Sinutab products in January. The healthcare company estimates that it recalled approximately 225 million bottles of OTC drugs in 2010.
The latest recall is an unfortunate addition to the Johnson & Johnson story as it continues to battle ongoing concerns about its reputation and the value of its brands to consumers.
In a January 15 story in The New York Times, Natasha Singer and Reed Abelson wrote:
While the drugstore signs that helpfully suggest “Try CVS/pharmacy brand” are intended to assist frustrated shoppers in identifying alternatives to missing brand-name products, they also serve as constant reminders of another of J.& J.'s continuing problems: It must persuade millions of disappointed customers to once again pay a premium for products that may no longer seem to be of any higher quality than the less expensive store brand.